IGFBP2 and hepatocellular carcinoma: In conclusion, our comprehensive investigations of IGFBP2 expression and its functional role in HCC patients, HCC cell lines, and nude mouse tumor xenograft models have provided evidence supporting the involvement of IGFBP2 in the induction of EMT through activation of the Wnt/β-catenin signaling pathway.